reSee.it - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
We are searching for a specific frequency to induce resonant vibrations in microorganisms. Using two identical tuning forks, both tuned to 440 Hertz, we observe that tapping one fork causes the other to vibrate sympathetically. This principle is similar to how a singer can shatter a glass by matching its resonant frequency. We explore the idea of using resonant frequency therapy to target living cells, specifically cancer cells. After testing numerous frequencies over 15 months, we discover that using two frequencies—one low and one high, with the higher being 11 times the lower—can shatter microorganisms. This technique shows promise against leukemia cells, causing them to fragment and die when exposed to specific frequencies between 100,000 and 300,000 Hertz.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker developed a protocol, BioStrike, and believes it extended Harry Reid's life. In 2015, the speaker petitioned the FDA to use the treatment at diagnosis, hypothesizing that chemotherapy and radiation wipe out natural killer and T cells. The FDA required testing on end-stage patients who had failed standard care. Despite patients' collapsed immune systems, the speaker reports complete remissions in Merkel cell carcinoma (patient lived six years), bladder cancer (patients alive 10-11 years), triple negative breast cancer, and metastatic pancreatic cancer (patient disease-free after five years, still alive at six). After 700,000 pages of response, the treatment was approved in late 2024. The speaker believes they are on the verge of treating sepsis and cites a recent case of clearing a month-long inflamed lung due to valley fever. The speaker is treating patients with bladder, pancreatic, and lung cancer. The speaker wants to disseminate this information to the scientific, medical, and regulatory communities.

Video Saved From X

reSee.it Video Transcript AI Summary
Cancer cells are vulnerable to frequencies between 100,000 and 300,000 hertz, with a 11th harmonic ratio. By adding the 11th harmonic, microorganisms are shattered within 3 minutes. The process destroys pancreatic, leukemia, and ovarian cancer cells, reducing their size and slowing growth rates by up to 65%. In laboratory experiments, 25% to 60% of leukemia cells were killed. Treatment rooms for children will feature healing plasma lights, silently destroying cancer cells.

Video Saved From X

reSee.it Video Transcript AI Summary
A physician named Dr. James Baer from Albuquerque, New Mexico, invented a method to shatter microorganisms using electronic signals. By adding the 11th harmonic frequency, these organisms are shattered like a crystal glass. This phenomenon is new and has caught the attention of biologists. Cancer cells are particularly vulnerable between the frequencies of 100,000 Hertz and 300,000 Hertz. Leukemia cells attempt to replicate but are shattered into fragments, causing their demise. This process is repeated with multiple leukemia cells.

Video Saved From X

reSee.it Video Transcript AI Summary
I used my background in physics and optics to find a better way to treat cancer without causing side effects like hair loss. I developed a harmless nanoparticle that heats up when exposed to laser light, killing the tumor cells it touches. By targeting the laser at the tumor site, we were able to completely eliminate tumors in lab mice with just one treatment over 15 days, without any side effects, chemotherapy, surgery, or radiation. This technology has the potential to revolutionize cancer treatment.

Video Saved From X

reSee.it Video Transcript AI Summary
The FDA has approved a new cancer treatment called histotripsy, which uses sound waves to dissolve liver tumors. This approach could replace traditional treatments like surgery, radiation, and chemotherapy, which often have harsh side effects. Histotripsy works by directing ultrasound waves at the tumor, creating tiny bubbles that burst and break the tumor apart. The body's immune system then cleans up the remnants. The method has been proven effective and safe through human trials since 2021. The treatment offers precision, real-time imaging, and potential immune system training against cancer cells. It provides a less physically taxing alternative with reduced recovery times and discomfort, while also minimizing potential drug interactions. Scientists believe histotripsy could become a universal cancer treatment and potentially a cure in the future.

Video Saved From X

reSee.it Video Transcript AI Summary
Histosonics' histoTripty, a noninvasive ultrasound technology, has been cleared by the FDA for use in hospitals worldwide. This treatment, known as histotripsy, uses ultrasonic pulses to disrupt tumor cells with minimal recovery time for patients. Liver cancer patients, who often have limited treatment options, could benefit from this precise and effective therapy. The Edison Platform, a robotic arm developed by Histosonics, enables clinicians to target tumors and monitor the treatment in real time. The success of human trials and FDA approval paves the way for histotripsy to be used in a wider patient population, potentially extending its applications to other types of tumors and even non-cancer conditions. This technology has the potential to revolutionize healthcare.

Video Saved From X

reSee.it Video Transcript AI Summary
A multiple wave oscillator was used to cure the speaker's father of quadriplegia. After treating him for 4 weeks, 6 weeks later, his father walked out of the hospital on crutches. The speaker also mentions a TED Talk by Anthony Holland, where he explains that frequencies between 100,000 hertz and 300,000 hertz can kill cancer cells. This information challenges the conventional understanding of cancer treatment.

Video Saved From X

reSee.it Video Transcript AI Summary
Hystotripsy, a new therapy approved by the FDA, uses ultrasound technology to treat liver cancer. High energy sound waves create micro bubbles in the tumor, causing the cells to break down and kill the tumor. Dr. Chen Chi, a professor at the University of Michigan, compares the procedure to a nanobomb. Initially, many in the scientific community believed ultrasound technology as a treatment would be impossible. However, Hystotripsy shows promise for treating other cancers, cardiovascular and brain diseases, and stimulating the immune system. The treatment is noninvasive, with short recovery time and minimal side effects compared to chemo or radiation. This sound-based therapy offers potential for curing cancer and other diseases without severe side effects.

Video Saved From X

reSee.it Video Transcript AI Summary
A new cancer treatment called histotripsy, approved by the FDA, uses sound waves to dissolve liver tumors with minimal side effects. This method breaks tumors apart using ultrasound waves, allowing the body's immune system to remove them. Histotripsy is precise, targeting only the tumor, and offers real-time imaging for monitoring. Studies show it may boost the immune system's ability to fight cancer. Patients experience quicker recovery and less discomfort compared to traditional treatments. Histotripsy could become a universal cancer treatment and potentially a cure in the future.

Video Saved From X

reSee.it Video Transcript AI Summary
The MedBeds are a holographic technology that uses color, light, and sound. This knowledge has existed on Earth since before Atlantis and has also existed off-world for tens of thousands, possibly millions of years with other star nations and star- traveling pioneers. They understood long ago that our bodies are holographic and essentially made of color, light, and sound. It wasn’t until about 2,530 years ago that science began to prove this by examining the body under an electron microscope, where what was seen was light rather than physicality. The holographic camera used in MedBeds takes a picture of the body that, because it is holographic, represents the present time and reaches back to conception. The process involves going through a series of slides captured in this single image to identify the healthiest states of various organs and tissues—kidneys, liver, muscle, knees, brain, heart, etc. Those slides are pulled out, and a new hologram is created from them. This holographic picture is then overlaid onto the physical body, effectively healing and renewing it while the person is present. According to the speaker, this knowledge is fully understood by certain groups who have not been suppressed, whereas in Earth and in other star systems controlled by the Orion group, humans have not had access to this education. The MedBed technology has been created and is in use, likely within black projects, and has been suppressed for a long time. Once the truth emerges, people will undergo emotional phases—disbelief, anger, and eventually resolve that such suppression should never happen again. Regarding practical use, the MedBeds could enable living to at least 100 years easily, with potential lifespans into the 200s or even 300–400 years. This would allow individuals to accumulate wisdom from disclosures and to build a solid foundation for future generations, ensuring they are ready to receive knowledge without being manipulated or controlled. The technology operates under a principle of consistency used by evolved star nations, with the aim of preventing exploitation. The MedBed’s frequency creates energy patterns that access and organize DNA, which is described as an antenna drawing frequencies and energies from the quantum field. What you think becomes what you create, and how you see yourself determines who you become. Home-use of MedBeds is not planned initially; they will be deployed at specific locations and rolled out by the military, with trained staff to prevent misuse. All treatments are said to be free, and the selection of operators will be restrictive and driven by love and compassion rather than profit. Other capabilities include age regression of at least twenty years, and potentially regrowing organs and limbs. For example, for organ failure or amputees, MedBeds could render prostheses unnecessary if organs or limbs can be regrown, transforming industries and restoring wholeness for those who have sacrificed themselves, such as veterans. The broader narrative frames humanity as part of a vast galactic family, previously isolated by groups that controlled the Earth's surface, with disclosure and healing signals signaling the end of that era.

Video Saved From X

reSee.it Video Transcript AI Summary
Humans possess natural killer cells, present for 460 million years, that protect against infection, cancer, and trauma. Current cancer treatments like chemotherapy, radiation, and steroid therapy destroy these cells. A new therapy, approved in 2024, aims to activate these natural killer cells, enabling the body to fight cancer. One injection can unlock these cells so they proliferate and protect you from cancer. Bladder cancer patients have remained disease-free for ten years using this therapy. According to the speaker, the prior presidential administration blocked this therapy along with a COVID treatment and vaccine. This therapy may also treat long COVID, HIV, and sepsis. The speaker plans to discuss this further in a series called "Cancer Decoded."

Video Saved From X

reSee.it Video Transcript AI Summary
Organisms are shattered using electronic signals, similar to radiation but without drugs. Vibrating forks at 440 hertz send energy pulses to shatter microorganisms. Resonant frequency therapy induces vibrations in cells, with pulsing output for targeted destruction. Using 2 input frequencies, one low and one high (11 times the lower), microorganisms can be shattered. Broadcasting an 18 gigahertz signal in pulses can cause lipid nanoparticles to release pathogenic contents, potentially causing a Marburg epidemic.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0: Medicine follows a chain from diagnosis to prognosis. If the diagnosis is misdiagnosed as a genetic disease, the prognosis won’t match what’s actually happening. Speaker 1: The ultimate approach is to look under the microscope at a biopsy. People rely on staging—stage one, two, three, four—a system used for over a hundred years. There are also stage zero ideas where there might be something or nothing. Then they remove breasts, use toxins, and do aggressive treatments to some patients. They define stage four, but what does that really mean? We look at tissue removed from the body, examine it under a microscope, and assess how many mitotic figures there are and how crowded the cells are. The pathologist makes a decision, which is passed to the surgeon or oncologist to tell the patient they have this kind of disease, stage three or stage four, depending on cell crowding and mitotic figures. The problem, which has persisted for decades, is that we take a biopsy of a tumor—a section of it—and the pathologist quickly decides. Then we stick the patient with something that can actually make things worse and spread the disease. I have dozens of articles showing that biopsies from breast, colon, liver, and lung can spread the tumor through the body, creating medicine. Why? I say: don’t do anything. Don’t poke the bear. Shrink it down, make it weak, then come in and take the whole thing out. Why stick it for nothing? Just remove the whole thing after you shrink it with metabolic therapy. Then what they say is, this is not an aggressive tumor. Yes, because we shrunk it a lot. If you had stabbed it initially, it might have said it would kill you. But you have to know the biology: you don’t poke the bear; you take the food away from it. It becomes docile, you can cut it out, then follow with non-invasive imaging. We have non-invasive imaging—CT, PET, MRIs—and you can start looking at things before you poke them. If it goes away, why poke it in the first place? So we have all these tools available, but they aren’t used in the correct order or way. Once the knowledge comes out, people will realize what I’m saying and start doing things the right way.

Video Saved From X

reSee.it Video Transcript AI Summary
A new FDA-approved therapy called AMTOGV is now available at the University of Chicago Medicine to treat melanoma. This treatment, known as tumor infiltrating lymphocyte therapy, involves removing T cells from a tumor, multiplying them in a lab, and infusing them back into the patient. This innovative therapy offers long-term control and potential cure for advanced melanoma patients. Additionally, this treatment may be applicable to other cancers where the immune system can recognize the tumors, such as lung and cervical cancer. Exciting advancements in cancer treatment are on the horizon.

Video Saved From X

reSee.it Video Transcript AI Summary
Cancer can be targeted and destroyed using specific frequencies between 100,000 and 300,000 hertz. By adding the 11th harmonic, microorganisms are shattered within about 3 minutes. This process has been observed in various experiments, including attacks on pancreatic cancer and leukemia cells. The destruction of cancer cells leads to changes in shape and size, and the tumor shrinks. Laboratory experiments have shown a 25% to 42% average kill rate for leukemia cells, with some cases reaching 60%. Additionally, the growth rate of cancer can be slowed by up to 65%. This non-toxic and painless treatment can potentially transform cancer treatment rooms for children.

Video Saved From X

reSee.it Video Transcript AI Summary
Biopsy is the only way to diagnose cancer, but it has its drawbacks. Breaking the fibrin sheath around a tumor during a biopsy can cause it to spread. A ballerina who had a biopsy experienced the growth of little tumors around the biopsy site. A histological diagnosis is needed, where a pathologist examines the slide to determine the type of cancer. However, this diagnosis doesn't provide much help. It is also a sales technique to justify specific drugs for treatment. Research shows that biopsies, surgeries, high dose chemo, and radiation can all lead to metastasis. These treatments may provide short-term reduction of the primary tumor, but the cancer often returns later.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 and Speaker 1 discuss access to treatment protocols and the scope of their metabolic approach to cancer. Speaker 1 notes they recently published a comprehensive, open-access protocol for glioblastoma in Biomedical Central, co-authored with Doctor Thomas Durai and over 20 scientists, physicians, nutritionists, and dietitians. The paper also marks the launch of the new Society for Metabolic Oncology. The protocol targets glioblastoma, a deadly brain cancer; Speaker 1 highlights that the same metabolic issues—cancers’ need for glucose and glutamine and their inability to burn ketones or fatty acids—apply across cancers such as lung, colon, breast, and bladder. He asserts that glioblastoma has seen no major advancement in management for a hundred years and attributes part of the problem to how brain irradiation can increase glucose and glutamine in the tumor microenvironment, potentially hastening decline. Speaker 1 emphasizes that the protocol for glioblastoma could be used for other cancers and centers on “pulling the plug on the fermentable fuels.” The regimen involves a phase of mild exercise, monitoring the glucose ketone index (GKI), and transitioning patients from dangerous metabolic states to more manageable ones to reassess treatment strategies and progressively reduce tumor activity. He stresses they are not claiming a cure; instead, they aim to “manage cancer effectively,” enabling patients to maintain a high quality of life whether or not the tumor regresses. Speaker 1 shares a clinical example: Pablo Kelly, who died last year, lived ten years with glioblastoma; he married and had three children. Although never cured, his tumor was put into an indolent state. Pablo died after a fourth surgical debulking; the tumor had been reduced and became operable after metabolic therapy, though it was never completely eradicated. The discussion notes that initial diagnosis described his tumor as inoperable, with a prognosis of death within twelve months if treated with large doses of chemo and radiation; he avoided radiation and chemotherapy and pursued metabolic therapy. The tumor then shrank enough to allow subsequent surgery over years, illustrating a shift from an aggressive to a more indolent disease course. Speaker 0 clarifies that “debulking” means removal of tissue. Speaker 1 reiterates their stance: cancer can be managed, changing its diagnosis from extremely aggressive to indolent, but they avoid using the word cure. They acknowledge uncertainty about long-term cures and note that standard care does not guarantee cure, while suggesting their approach can achieve substantially better outcomes.

Video Saved From X

reSee.it Video Transcript AI Summary
In a pilot clinical trial, researchers extracted teeth from patients who were going to get braces. They applied forces to induce root erosion and used an ultrasound device on each patient. After 4 weeks, the teeth that didn't receive stress showed erosion, but the ultrasound application resulted in the formation of new dental tissue. Encouraged by these results, they applied even higher forces in another experiment and found that ultrasound preserved the root while the inside root was severely resolved in the control group. This confirms that ultrasound is effective in orthodontic treatments.

Video Saved From X

reSee.it Video Transcript AI Summary
- "Hey. Did you know your liver is basically your body's engine room? It powers your energy, keeps your blood clean, and controls your metabolism." - "Low intensity ultrasound can calm down inflammation, reduce early signs of scarring, boost how your body handles sugar, and help balance your cholesterol and liver enzymes." - "People in early studies saw better energy, clearer thinking, less bloating, and healthier blood markers after consistent use." - "You've got two main targets." - "First is the porta hepatis." - "That's the gateway to your liver." - "It's about two to four centimeters below your right rib cage near the middle." - "The second is directly over the liver tissue." - "For direct liver work, use a low pulsed setting, around 0.08 to 1.5 watts, three to five times a week."

Video Saved From X

reSee.it Video Transcript AI Summary
Dr. Reitzen is testing a UV light device from UVLRX that treats flu symptoms. The technology of using UV light to treat viruses and bacteria has been around for over 100 years and won a Nobel Peace Prize. UVLRX changed the delivery system to go directly into the body. The procedure lasts about an hour, similar to a regular IV. A catheter is inserted, then replaced with an adapter that carries light directly into the vein. Some patients are intimidated, while others are excited by the light. Dr. Reitzen states that, anecdotally, patients have experienced significant results, feeling less sick and experiencing shorter flu durations, lasting two or three days instead of fourteen. She states that the flu study aims to gather data on symptom duration and severity. The flu can be fatal.

Video Saved From X

reSee.it Video Transcript AI Summary
The only definitive way to diagnose cancer is through a biopsy. However, biopsies can disrupt the tumor's protective sheath, potentially causing it to spread. A patient experienced this firsthand after a biopsy led to the emergence of multiple tumors. While a histological diagnosis from a pathologist identifies the cancer type, it often serves as a justification for specific drug treatments, which are approved by the FDA and covered by insurance. Unfortunately, research indicates that these treatments, including chemotherapy and radiation, often lead to metastasis. Patients may initially feel a sense of remission, but cancer frequently returns within months.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker describes cancer as an autonomous entity that hides, like a virus, by blocking expression through genomic sequencing. Low-dose chemotherapy or low-dose radiation (SBRT) can be used to stress the cancer and "smoke it out," exposing it to the immune system. The speaker advocates for a simultaneous, multi-pronged approach: expose the tumor, activate natural killer (NK) and T cells (using a "BioShield" molecule to upregulate them and drive memory T cells), educate T cells with a vaccine, activate macrophages, and suppress suppressors. This approach aims to use the tumor as a vaccine by educating T cells to recognize foreign molecules. The speaker claims this protocol is done entirely on an outpatient basis, without the typical suffering associated with conventional cancer therapy. They report bladder cancer patients in complete remission for nine years using this method.

Video Saved From X

reSee.it Video Transcript AI Summary
Cancer cells are vulnerable to frequencies between 100000 Hertz and 300000 Hertz, with the higher frequency being 11 times the lower. By adding the 11th harmonic, microorganisms are shattered within 3 minutes. The video shows the destruction of various cancer cells, including pancreatic cancer and leukemia cells. The tumors shrink and break up in controlled experiments. The treatment rooms for children will have healing plasma lights above, shattering cancer cells painlessly.

The Peter Attia Drive Podcast

363 ‒ A new frontier in neurosurgery: brain-computer interfaces, new hope for brain diseases, & more
Guests: Edward Chang
reSee.it Podcast Summary
Neurosurgery still feels like peering into a black box, yet the frontier is shifting as brain computer interfaces promise new ways to diagnose, treat, and restore function. The episode centers on GBMs, strokes, and other brain diseases, highlighting awake surgery and real-time brain mapping as a way to maximize tumor removal while preserving language and movement. The brain itself has no pain receptors, so a patient can be awake under local scalp anesthesia and light sedation while surgeons work. The guest recalls that seeing the cortex pulse and measuring neurons sparked her lifelong fascination with brain function. Historical milestones anchor the field, from Harvey Cushing, the father of modern neurosurgery, to Wilder Penfield and awake epilepsy surgery. The discussion traces cranial openings to the present, where laser probes, focused ultrasound, and endovascular techniques now shrink invasiveness and extend life. Vascular work that once required large craniotomies is increasingly done through catheters, coils, and stents, and clot retrieval has turned strokes into treatable emergencies. The speakers emphasize that stroke care now resembles heart attack care, with rapid, catheter-based interventions redefining outcomes and shortening hospital stays. GBMs emerge as particularly lethal because of their heterogeneity and diffuse invasion beyond visible margins. The conversation notes that modern centers now perform genetic profiling of tumors, guiding targeted chemotherapy and immunotherapy as we learn to unleash the immune system while preserving normal brain tissue. The blood-brain barrier remains a barrier, but focused ultrasound and related approaches are opening it to deliver molecular therapies. Surgery still extends survival by enabling more complete resection, but the goal is to combine biology, imaging, and immune strategies to create personalized, durable control. Brain-computer interfaces become central as a practical therapy, illustrated by the Bravo trial and Ann’s case. An array of 253 ECOG sensors placed on the speech-related cortex captured a patient’s intention to speak and translated neural signals into text, achieving initial accuracy around 50% and reaching near-perfect decoding within a week. New work demonstrates streaming decoding with sub-second latency. The approach combines neural decoding with language models to generate fluent speech, and plans toward fully implantable, wireless devices. The discussion also envisions regenerative and biotech advances, including stem cell strategies, while acknowledging ethical questions.
View Full Interactive Feed